- |||||||||| VH4524184 / ViiV Healthcare, GSK
Trial completion, Trial completion date, Trial primary completion date: VH4524184 Proof-of-Concept in Treatment-Na (clinicaltrials.gov) - Sep 23, 2024
P2, N=22, Completed,
Recruiting --> Completed | Trial completion date: Sep 2024 --> Jun 2024 | Trial primary completion date: Sep 2024 --> Jun 2024
- |||||||||| VH4524184 / ViiV Healthcare, GSK
Enrollment open, Trial completion date, Trial primary completion date: First Time in Human Study of Long Acting VH4524184 Formulations (clinicaltrials.gov) - Jun 24, 2024
P1, N=72, Recruiting,
Recruiting --> Completed | Trial completion date: Sep 2024 --> Jun 2024 | Trial primary completion date: Sep 2024 --> Jun 2024 Not yet recruiting --> Recruiting | Trial completion date: Nov 2026 --> Jan 2028 | Trial primary completion date: Feb 2025 --> Mar 2027
- |||||||||| VH4524184 / ViiV Healthcare, GSK
Enrollment open: VH4524184 Proof-of-Concept in Treatment-Na (clinicaltrials.gov) - May 9, 2024
P2, N=28, Recruiting,
Not yet recruiting --> Recruiting | Trial completion date: Nov 2026 --> Jan 2028 | Trial primary completion date: Feb 2025 --> Mar 2027 Not yet recruiting --> Recruiting
- |||||||||| VH4524184 / ViiV Healthcare, GSK
In vitro characterization of VH4524184 (VH-184, S-365598), a new third-generation integrase strand transfer inhibitor (INSTI) with a unique resistance profile (Poster board: 114) - May 2, 2024 - Abstract #AIDS2024AIDS_1400;
The embargo on all abstracts, including oral abstract, poster exhibition, e-poster and late breakers, will lift on Tuesday, 23 July 2024, at 10:00 am Central European Summer Time (CEST). If an abstract is part of an official AIDS 2024 press conference that occurs before that time, the embargo on that abstract lifts at the start of the official press conference.
- |||||||||| VH4524184 / ViiV Healthcare, GSK
Phase 1 study of VH4524184 (VH-184), a new third-generation integrase strand transfer inhibitor (INSTI) with a unique resistance profile (Hall B0b/Channel 5) - May 2, 2024 - Abstract #AIDS2024AIDS_409;
The embargo on all abstracts, including oral abstract, poster exhibition, e-poster and late breakers, will lift on Tuesday, 23 July 2024, at 10:00 am Central European Summer Time (CEST). If an abstract is part of an official AIDS 2024 press conference that occurs before that time, the embargo on that abstract lifts at the start of the official press conference.
|
